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Background: A growing body of research has identified family interventions to be effective in treating young
people’s substance use problems. However, despite this evidence, take-up of family-based approaches in the UK
has been low. Key factors for this appear to include the resource-intensive nature of most family interventions
which challenges implementation and delivery in many service settings and the cultural adaptation of approaches
developed in the USA to a UK setting. This study aims to demonstrate the feasibility of recruiting young people to
a specifically developed family- and wider social network-based intervention by testing an adapted version of adult
social behaviour and network therapy (SBNT).
Methods: A pragmatic, randomised controlled, open feasibility trial delivered in two services for young people in
the UK. Potential participants are aged 12–18 years referred for drug or alcohol problems to either service. The main
purpose of this study is to demonstrate the feasibility of recruiting young people to a specifically developed family
and social network-based intervention. The feasibility and acceptability of this intervention will be measured by
recruitment rates, treatment retention, follow-up rates and qualitative interviews. The feasibility of training staff
from existing services to deliver this intervention will be explored. Using this opportunity to compare the effectiveness
of the intervention against treatment as usual, Timeline Follow-Back interviews will document the proportion of days
on which the main problem substance was used in the preceding 90-day period at each assessment point. The
economic component will examine the feasibility of conducting a full incremental cost-effectiveness analysis of
the two treatments. The study will also explore and develop models of patient and public involvement which
support the involvement of young people in a study of this nature.
Discussion: An earlier phase of work adapted social behaviour and network therapy (adult approach) to produce
a purpose-designed youth version supported by a therapy manual and associated resources. This was achieved
by consultation with young people with experience of services and professionals working in services for young
people. This feasibility trial alongside ongoing consultations with young people will offer a meaningful understanding
of processes of delivery and implementation.
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Early onset of drug use, including alcohol, in children
and young people has been associated with later prob-
lematic use [1,2], as well as a range of other problems
including risky sexual behaviour, injury, antisocial behav-
iour and changes in brain development [3-5]. Cannabis
and alcohol are the two most commonly consumed drugs
by young people in England, accounting for 90% of treat-
ment admissions for young people [6]. Fifteen to 16 year
olds in the UK have one of the highest rates of underage
drinking and drunkenness in Western Europe, with the
UK also amongst ten European countries with the highest
proportion of students reporting smoking cannabis within
the past 30 days [7].
Research has shown that substance use amongst young
people can adversely affect relationships with parents,
carers and other family members [8], but also that family
involvement in interventions can influence the course of
the problem in a positive way and act as a protection
against substance-related problems [9]. As a consequence,
a range of preventive and treatment approaches have
focused on the family; and in the UK, there has been a
strong focus on preventive programmes. A systematic
review by Foxcroft and colleagues [10] identified the
Strengthening Families Programme [11], developed in
the USA, as the most promising, with positive outcomes
in both the short and the long term. Emerging findings
from the application of this model to the UK context have
shown some promise [12].
The four most evaluated family interventions used with
young people include ‘multisystemic therapy’, ‘integrated
family and cognitive behavioural therapy’, ‘multidimen-
sional family therapy’ and ‘brief strategic family therapy’
[13]. Reviews of evaluation studies have shown these ap-
proaches to be effective in reducing drinking and drug
use amongst young people [13-15]. However, problems
revolve around engagement of family (however defined),
treatment decay and translating research into practice.
Firstly with regard to family engagement, services fre-
quently have problems engaging individual family members
[16]. Furthermore, the definition of ‘family’ is contested and
carries implications for the delivery of family interventions
[17]. Young people (YP) with substance use problems fre-
quently come from disrupted and sometimes ‘complex’
families and may be looked after by single parents, grand-
parents, other relations or the state (e.g. Lloyd 1998; Boys
et al. 2003 [2,18]). Traditional, systemic family approachesmay be difficult to deliver in such situations. Secondly, re-
searchers have pointed to the particularly rapid decay in
treatment effect for adolescents’ drug and alcohol problems
[13,15]. Thirdly, in terms of translating research into prac-
tice, the intensive training required [14] and the lengthy
time required to deliver systemic family interventions can
discourage practitioners from implementing them. UK
National Treatment Agency statistics, for example, sug-
gest that only 2% of interventions with the under-18 s
consisted of ‘psychosocial and family work’ and 6%
‘psychosocial, family work and harm reduction’ [6].
The large majority of young people with substance misuse
problems receive psychosocial interventions focused on the
individual user that do not engage family members. Like-
wise, our recent survey conducted in the UK with services
for adult family members showed that even those family in-
terventions recommended by the National Institute for
Health and Care Excellence (NICE) [19] such as Behavioural
Couples Therapy [20] are rarely implemented [21].
A further potential barrier may be the need for cul-
tural adaptation of approaches developed in the USA to
a UK setting. There is growing awareness of the need to
adapt evidence-based treatments to different cultural
groups and healthcare settings in order to ensure suc-
cessful implementation [22-24].
Social Behaviour and Network Therapy (SBNT) is an
intervention developed in the UK shown to be effective
with harmful drinkers [25], which utilises cognitive and
behavioural strategies, helping clients build family and
social networks which are supportive of behaviour change
and goal attainment. The focus is on addressing substance
misuse by engaging with a network of positive support for
lifestyle change. SBNT may also have relevance to adoles-
cent populations as it helps sustain engagement with
vulnerable young people by widening the reach of the
intervention beyond the traditional family to include
supportive peers. The intervention aims to integrate
strategies found to be effective in other family and net-
work approaches, is based on the concept of enhancing
social support for a positive change in substance use
and consists of a series of core and elective topics used
within sessions. Core strategies include motivational tech-
niques, improving communication and coping mechanisms,
and given the nature of substance misuse, developing a
network-based relapse management plan. The therapeutic
approach also has scope to address client-focussed elective
areas, for example, educational requirements [26].
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the current SBNT approach to produce a purpose-designed
therapy manual and associated resources suitable for use
with young people (Youth-SBNT or Y-SBNT). This was
achieved by extensive and ongoing Patient and Public
Involvement (PPI) with young people with experience
of services, as well as consultation with treatment profes-
sionals working with young people. Whilst retaining the
main aspects of the approach that were established to be
relevant to the young population, the adaptation showed
the need to pay particular attention to the identification of
potential network support that is wider than the biological
family and includes peers and important formal supports.
This study aims to demonstrate the feasibility of recruit-
ing young people to receive this specifically developed
family- and network-based intervention, establishing the
acceptability of the intervention to both young people and
their therapists.
Methods/Design
Design
The study is a pragmatic, randomised controlled, open
feasibility trial in which a specifically developed family-
and social network-based intervention is compared with
treatment as usual for young people aged 12–18 yearsFigure 1 Flow diagram of Y-SBNT study.referred for treatment of drug or alcohol problems to
two young people’s services. The study has been
granted ethical approval by the National Research Ethics
Committee West Midlands—Coventry & Warwickshire
(Reference: 14/WM/0021). A full flow diagram for the
study is shown in Figure 1.
Aims of the study
– To demonstrate the feasibility of recruiting young
people to a family- and social network-based
intervention (Y-SBNT) across two service sites.
– To test the feasibility of training staff from existing
young people’s addiction services to deliver the
family and social network intervention.
– To evaluate the level of treatment retention amongst
participants randomised to the family and social
intervention compared to treatment as usual.
– To explore through qualitative interviews the
participants’ views, acceptability and experiences of
the intervention and the study process.
– To explore through qualitative interviews the views,
acceptability and experiences of those attending
treatment sessions as members of the young
person’s network.
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12-month outcome quantitative data.
– To explore cost effectiveness in preparation for a
large definitive randomised controlled trial.
– To explore and develop models of patient and public
involvement which support the involvement of young
people in a study of this nature.
Participants and setting
This feasibility study is being conducted in two UK cen-
tres that are representative of the types of young people
services available across the UK:
– West Midlands, England: a service providing
information, advice, treatment and support for
problems related to the use of drugs, alcohol and
other substances for people less than 18 years of age.
The service consists of a multidisciplinary team
offering individual and group services to young people
with substance misuse problems and complex needs
and delivers both assessment and treatment.
– North East of England: a specialist service for
people less than 18 years of age that links with a
number of generic youth services and with other
primary care services such as general practitioners
(GPs) and school nurses. Workers are mainly from
the third sector who have extensive experience in
addictions and youth development.
Eligibility criteria
Young people (YP) are considered eligible if they:
– are aged 12–18 (males and females).
– have been newly referred and accepted for structured
intervention for drug and/or alcohol problems by either
treatment service during the period of recruitment.
– are willing and able to provide written informed
consent and deemed Gillick competent (United
Kingdom assessment made in regard to whether a
child under 16 has the capacity to consent to
treatment without parental or guardian consent) [27].
Young people are considered ineligible if they:
– have a concurrent severe mental illness that
precludes them from active participation.
– have a severe physical illness that precludes them
from active participation.
Study procedures
Identification
All YP newly referred to the two treatment services dur-
ing the recruitment period will be considered potential
participants.Eligibility assessment
All referred YP will initially take part in an assessment
session (routine part of the service referral and assessment
processes) either at the treatment agency, home or usual
place of treatment. Prior to conducting the assessment, a
competency test based on the Gillick test is routinely ad-
ministered to ensure that the young person is ‘competent’
to understand the implications of treatment as well as
provide independent and valid consent. Those found to be
appropriately referred and meeting the inclusion criteria
will be deemed potentially eligible for the trial.
Eligible YP who do not wish to take part (i.e. unwilling
to give consent) and those found to be ineligible will go
on to receive usual care from the service. Where offered,
reasons for non-participation will be collected to inform
future studies.
Eligible YP and their parents/person with parental re-
sponsibility will be given a leaflet and patient information
sheet (PIS) by the assessment staff. If they are interested
after reading the materials, a meeting will be arranged
with a researcher.
Consent procedure
During the meeting with the researcher, those eligible
and interested will have the study fully explained to them
and be given the opportunity to ask questions. For those
that agree to participate, written informed consent to par-
ticipate in the trial will then be obtained.
The research process must ensure that informed deci-
sions are made by YP and their parents/person with paren-
tal responsibility whether or not to take part in the trial.
Competence is not related to age in a simple way but de-
pends on a child’s ability to understand, weigh the options
and reach an informed decision [28].
For the purpose of this study, the following will apply
in line with the National Children’s Bureau (NCB) guide-
lines [29]:
– If consent is not forthcoming from a parent/person
with parental responsibility but the young person
(aged 12–15) does consent, they will still enter the trial.
– For those aged 16 and above, consent will be only be
sought from the young person as those aged between 16
and 18 are presumed to be competent to give consent.
– If consent is given by a parent/person with parental
responsibility but the young person does not consent,
the young person will not enter the trial.
However, the possibly ‘chaotic’ and complex lives of
many of these YP has to be considered and as such, dis-
cussion about consent in all cases will be handled in a
sensitive manner. It is expected, on the basis of previous
experience, that YP and their parents/person with paren-
tal responsibility decisions will usually be concordant.
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to assist with treatment retention and follow-up.Randomisation process
Participants will be randomised by a secure remote ran-
domisation service run by the fully registered York Trials
Unit, UK. Randomisation, stratified by centre, will allocate
participants following baseline assessment to either treat-
ment as usual (TAU—control treatment) or the adapted
youth social network intervention (Y-SBNT).Intervention content
An initial phase of work was conducted in order to adapt
the current social behaviour and network therapy ap-
proach [26] to produce a purpose-designed therapy
manual. This was achieved through reviewing the current
evidence-based literature and consultation with YP with
experience of services and professionals working in YP
services. This was conducted as part of PPI work through
separate interviews, meetings and consultation events.
The resultant Y-SBNT will be delivered according to
the therapy manual and consists of an initial appointment
followed by five further approximately 50-min SBNT ses-
sions over a maximum period of 12 weeks (aiming for one
per week where possible or adapting frequency depending
on clinical need). The intervention will be delivered by a
therapist trained to do so and can be delivered at the
treatment agency, the participant’s home or their usual
place of treatment. A key strength of the SBNT approach
is the primary focus on addressing drug and alcohol prob-
lems by engaging with a network of positive support for
lifestyle change. Therefore, the first session will involve an
introduction to the treatment method, identification of
the young person’s social network and review of important
people. Using this as a platform, subsequent core strat-
egies of the adapted Y-SBNT approach will include identi-
fying and developing achievable goals, developing network
support and improving communication and coping
mechanisms and developing a network-based relapse
management plan. The participant is encouraged to
invite members of their network to the treatment ses-
sions. An important aspect is to ‘think network’ [26],
and this involves the therapist always thinking about
the young person within a social context and consider-
ing the impact of the YP substance-related behaviour
upon others and the potential for the YP accessing and
developing social support. The therapeutic approach
has scope to address client-focussed elective areas, for
example, educational requirements [26]. The Y-SBNT
manual combines the most effective components of the
SBNT intervention used in earlier studies with adults with
substance use problems as well as those identified as im-
portant through consultation with YP, families and staff.Those participants randomised to receive TAU will
continue to receive their usual care delivered by their ser-
vice, with appointments offered as required in the first
12 weeks. TAU generally focuses on engagement, descrip-
tion of substance use, current issues that the young person
brings to sessions and which seem relevant to the sub-
stance use and practical matters such as housing or school
exclusion. Participants allocated to TAU will be seen by a
therapist not trained in Y-SBNT. Content of TAU sessions
will be recorded and assessed at the end of the study.
Concurrent treatment will be available to both groups
and can occur wherever there is a need for any identified
medical treatment as and when necessary (e.g. treatment
for attention deficit hyperactivity disorder).
Training
Training in the intervention followed the format adopted
in previous pilot work in this area [30]. Service therapists
from the two participating clinical centres will be invited
to express an interest in study participation and receive
training in Y-SBNT. Given the pragmatic nature of this
feasibility study, therapists will be selected on the basis of
their expression of interest. At the time of writing, there
are significant changes taking place in the services in
the UK and staff turnover is high. Whilst random selec-
tion of therapists may be preferable, the risks associated
with implementing such a process within routine ser-
vices are deemed to be too high in terms of the main-
tenance of therapists’ engagement and retention within
this early pilot phase.
Once selected, therapists will receive an initial 1-day
training session to introduce the key concepts and proce-
dures involved in the intervention. This will be supported
by the original SBNT manual, specific written materials
and resources to be used with young people. Staff will pilot
the methods with a minimum of one clinical case prior to
the commencement of the trial, until the intervention
is being delivered with sufficient fidelity. Supervision
thereafter will be provided fortnightly where each case
is reviewed and discussed in detail with reference to the
key components of the approach and available resources.
Blinding
Due to the nature of the interventions used within this
study, blinding of the participants, therapists and the re-
searchers is not possible. However, baseline data will be
collected prior to randomisation and those involved in the
analysis of the data will be blinded to treatment allocation.
Qualitative data
A key aim of this feasibility study is to establish the accept-
ability of the Y-SBNT intervention to the YP and their fam-
ilies and social network members. Participant interviews
will be undertaken to explore these issues at 3 months post
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nature and built on the work conducted as part of UKATT
[31-34] and previous studies of SBNT with drug users (e.g.
Copello et al. [30]) in order to explore perceptions of the
effectiveness and utility of the new intervention. We aim to
understand which elements of the treatment were benefi-
cial and acceptable in the care of YP. This will complement
the analysis of the quantitative data and identify ways in
which Y-SBNT may need to be modified in preparation for
a definitive trial.
Semi-structured interviews will also be conducted with
members of the young person’s network who attend treat-
ment sessions. All network members will be approached;
and for those interested, interviews will be conducted by
researchers either face-to-face or by telephone 3 months
post randomisation. Interviewing network members will
provide essential information about their thoughts on be-
ing involved in such a process including any impact it has
on them and their relationship with the young person.
This will also provide an opportunity to explore whether
taking part in the treatment was acceptable to them and
the perceived influence of their involvement on the young
person’s substance use. A sample of ten individuals
(one network member for every six YP participants at
each service) will be interviewed.
In addition, the therapists delivering the Y-SBNT inter-
vention and the TAU therapists will be interviewed at a
single point; following the completion of all 3-month
post-randomisation follow-up assessments. The interviews
with Y-SBNT therapists will be used to explore a number
of themes, including the training and implementation
process, how the intervention differs from usual treatment
and how easy it has been to engage YP and their social
networks. These interviews will seek to identify potential
problems with the delivery of the intervention and trial
processes, with a view to ironing out any difficulties prior
to a full trial. Interviews with service managers will cover
similar ground, exploring issues of implementation but
also broader questions about the popularity of the inter-
vention amongst service staff.
All interviews will be conducted by trained researchers
using the appropriate topic guide for the person being
interviewed to promote consistency. The topic guides
cover areas including satisfaction and acceptability of the
intervention, aspects that were helpful or unhelpful from
the participant’s perspective, the overall experience of the
treatment and suggestions for improvement. Written in-
formed consent will be gained prior to the qualitative inter-
views which will also be audio-recorded when permitted.
Patient outcome measures
This study also provides an opportunity to explore effect-
iveness of the intervention when compared to TAU and
inform any future trial of the most appropriate outcomemeasures. The main outcome will be substance use based
on the Timeline Follow-Back (TLFB) interview [35] and in
particular the proportion of days on which the main prob-
lem substance was used in the preceding 90-day period at
each assessment point (3 and 12 months). The TLFB
interview is based on a retrospective calendar review of
each day’s consumption and has been validated and widely
used with adolescent populations (e.g. Dennis et al. 2004;
Waldron et al. 2007; Levy et al. 2004 [36-38]). Utilising
the TLFB will allow the collection of detailed data on the
full range of licit and illicit drugs used by participants.
This will provide the opportunity to explore a range of
substance use outcome measures, with a view to inform-
ing the outcome measure used in the full trial.
A number of secondary patient outcomes will also be
measured. Behaviour, concentration, emotions and rela-
tionships with other people will be measured using the
Strengths and Difficulties Questionnaire (SDQ) [39] which
has been used extensively and demonstrates high levels of
reliability and validity [40,41]. Given the emphasis on fam-
ily and peer support of the intervention, structure and
quality of social network support will be measured using
the Important People Drug and Alcohol (IPDA) interview.
This measure, with good internal consistency and validity,
is considered useful to administer pre- and post-treatment
to assess the degree to which social network changes have
been achieved and to assess the extent to which these
changes still need to be made [42]. Family environment
will be measured using the 27-item relationship dimen-
sion of the Family Environment Scale (FES) [43] con-
sisting of cohesion, expressiveness and conflict subscales
(nine items each). It is designed to measure the atmos-
phere in the family household and will be used where
appropriate to the circumstances of the participant. Ex-
tensive development and validation work has been con-
ducted on the FES, with internal consistency, test re-test
reliability and content and construct validity all reported
as robust [44]. Health-related quality of life (HRQoL)
will be assessed using the European Quality of Life—5
Dimensions—5 Levels (EQ-5D-5 L) instrument. EQ-5D
is a standardised measure of health status developed by
the EuroQol Group in order to provide a simple, generic
measure of health for clinical and economic appraisal,
where health is characterised on five dimensions (mobility,
self-care, ability to undertake usual activities, pain, anxiety/
depression) [45].
All these patient outcome measures will be collected
during face-to-face meetings at baseline, 3 and 12 months
post randomisation. For those participants randomised in
the last 2 months of the recruitment period, final follow-
up may take place within a 10- to 12-month period.
At the end of treatment sessions 1 and 3, both the
young person and the therapist (Y-SBNT and TAU)
will complete the 12-item Working Alliance Inventory
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relationship.
The costs of delivering the two interventions will be
calculated on the basis of resources used. Participant use
of healthcare and social services as well as school at-
tendance and engagement, self-reported crime and con-
tact will be assessed through service-use questions at
baseline and 12 months post randomisation. We will use
utility values based on societal values using the York tar-
iff [47]. Data will be also be collected at each treatment
session on length of the event, who attended the session
as a network member, the therapist involved, location
and any materials used.Quality assurance of treatment delivery
Where consent is obtained, sessions in both treatment
arms will audio-recorded and reviewed. This will ensure
fidelity with the Y-SBNT manual and monitor the ele-
ments of TAU which will be carefully documented as
part of the feasibility study.Recruitment
Recruitment is planned to last 6 months.Compliance and withdrawal
The issue of compliance has been explored with YP and
also through an appraisal of academic reviews of family
interventions with YP conducted as part of an earlier
phase of work. Important strategies were identified to
minimise drop out including factors related to the ther-
apist style and orientation, structural factors, the actual
therapy orientation and additional factors such as provision
of a quick service response and use of mobile systems for
appointment reminders and communication with YP. The
intervention has, in addition, been developed to be flexible
and delivered through outreach in a range of settings, e.g.
schools, other services and participants’ homes.
Attrition from follow-up is a major threat to internal
validity, and longitudinal studies of substance users fre-
quently suffer from low follow-up rates; reflecting the
‘chaotic’ and complex nature of this group (e.g. Ziek et al.
[48]). This study will draw on aspects of Scott’s En-
gagement, Verification, Maintenance and Confirmation
(EVMC) model [49] to track and follow up participants
in order to minimise such problems. These include
building rapport with respondents, detailed locator in-
formation (including at least three tracing contacts),
periodic reminders, use of the same researcher to carry
out interviews at baseline, 3 months and 12 (final) months
and high street shopping vouchers to compensate for their
time completing interviews.Sample size calculation
Treatment service outcome data collected in the 6 months
prior to the trial showed that one of the participating ser-
vices currently receives approximately 45 new referrals
per month and carries a caseload of over 200 clients. The
second service had approximately 280 YP access in the
last year. Drawing on National Treatment Agency statis-
tics, it is expected that 90% of the sample will fall into the
target age range [6].
As this is a feasibility study, the main purpose is to as-
sess the acceptability and feasibility and to obtain infor-
mation that would inform the design of a larger full-scale
trial. Although a formal sample size calculation for a
feasibility or pilot study is not required, we calculated
the number of participants required so that an effect
smaller than that desired in the main trial can be ruled out
[50]. This will give a clear criterion on which to base the
decision to go ahead with the main trial following the feasi-
bility study.
For the main trial, we would want to detect 0.3 of a
standard deviation between the two groups. This would
require a sample size of approximately 350 patients. A
pilot study of 32 patients would be sufficient to exclude
this difference in the event of a zero or negative inter-
vention effect. We would conclude, unless there was a
clear explanation, that there was poor justification for
moving towards a fully powered main trial as it would
be unlikely that an effect size of 0.3 or greater would be
found in a main trial. If there is a positive intervention
effect in the pilot study, then we would conclude that
the main trial is worthwhile providing adequate recruit-
ment and follow-up rate was observed in the pilot study.
Given the patient population, a reasonably high level
of attrition may be expected. We feel that we will need
to recruit 60 participants to the trial to fully inform the
design and sample size of the main study.
Planned recruitment rate
It is expected that recruitment will be at the rate of ten
patients per month (five from each site).
Analysis
The main aims of this study are to demonstrate the feasi-
bility of recruiting YP to a family- and social network-
based intervention, test the practicalities of training staff
to deliver it and, importantly, to evaluate the acceptability
of the intervention to both the YP and the therapists.
Qualitative analysis
Interviews will be digitally recorded (where consent is
given) and fully transcribed. In line with our previous
work involving qualitative evaluation of SBNT [51],
analysis will be based on grounded theory methods [52].
Initial ideas will be identified and organised into higher
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group seminars. Some of the emerging findings will be
presented to a selection of the original participants in
order to check validity of the resulting interpretation.
Primary statistical analysis
The feasibility of this current study and the potential for
taking this forward to a large-scale study will be measured
in conjunction with the qualitative data by examining
recruitment rates, retention in treatment and follow-up
completion rates.
The primary clinical outcome measure for the study will
be the proportion of days on which the main problem
substance was used in the preceding 90-day period at each
assessment point. Analysis will be on an intention-to-treat
basis using two-sided, 5% significance. The primary ana-
lyses will compare Y-SBNT with TAU, and participants
will be analysed using a linear model accounting for
clustering of participants within therapists. Missing data
will be dealt with using sensitivity analyses to check the
robustness of the primary analysis. As this is a feasibility
study, the level of and reasons for missing data (where
available) will be reported to inform any full-scale trial. An
effect size will be calculated for average proportion of days
used in the 90-day period, with an estimate of zero or
above indicating that an effect size of 0.3 is plausible for
the main trial.
Secondary statistical analyses
Secondary outcomes will include SDQ and FES (relation-
ship dimension) and EQ-5D-5 L, all measured at 3 and
12 months. Using the IPDA, we will calculate the same
measure of social support calculated for the UK Alcohol
Treatment Trial (UKATT) [53] in order to compare
changes between baseline and follow-up for the young
people. In addition, we will explore structural and func-
tional components of the young persons’ social networks
using a number of the IPDA sub-scales and changes again
will be explored between baseline and follow-up. By
means of the WAI, the relationship between the young
person and therapist will be explored using descriptive
statistics and correlation where appropriate.
Economic analysis
The economic component of this trial will examine the
feasibility of conducting a full incremental cost-effectiveness
analysis of Y-SBNT compared to TAU. This will involve
piloting a short questionnaire, analysing responses and
calculating quality-adjusted life year (QALY) changes
using EQ-5D-5 L. We would not expect to see significant
changes between groups due to the small sample size in
this pilot.
A simple questionnaire will measure participants’ use
of healthcare retrospectively. The economic analysis willassess the feasibility of using such a questionnaire in the
12–18 population. The questionnaire will ask about
primary care, hospital visits and hospital stays. In a full
trial, resource use data will be multiplied by national
average unit costs to calculate per participant costs in
the 3-month period before the intervention and the 3-
month period after receiving Y-SBNT or TAU.
Quality of life will be measured by EQ-5D-5 L at base-
line and each follow-up time point. The use of EQ-5D-
5 L enables the estimation of QALYs. Measuring health
status using QALYs follows the recommendations of
NICE [54] and enables the value for money afforded by
treatment to be compared to a range of other healthcare
interventions.
Treatment fidelity analysis
Audio recordings of the treatment sessions will be used
to rate the quantity and quality of the treatment compo-
nents delivered by the therapists and their adherence to
the Y-SBNT treatment manual. Using the extensive work
conducted as part of the UKATT trial and the fidelity
scale already developed [55], we will attempt to adapt
this scale to measure fidelity to Y-SBNT. Frequency and
quality of behaviour change techniques used and found
to be integral to SBNT in previous work and including,
for example, items such as a ‘social interpersonal focus
in session’, ‘discussion of social support’ and ‘involving
others’ will be rated. Depending on the sample available,
this adapted scale will be tested on this population and
we will attempt to test the validity and reliability as dis-
cussed by Tober et al. [55].
A number of TAU recordings will be assessed to try
and identify the components of TAU. Recordings of
10%–20% sample of sessions across all therapists and
both centres from the middle and end of the therapy will
be assessed. Correlational analysis of the data derived
from these ratings will be performed to detect protocol
adherence and discriminability between the treatments.
Public involvement
This study will allow us to explore ways in which young
people with experience of using services can be involved
in a study of this nature. As part of the significant PPI
component of this study, the project team is actively in-
volving a group of YP with a history of treatment for sub-
stance abuse throughout the research process. In phase 1,
YP were supported to work alongside the research team in
order to ensure that the intervention is acceptable and
relevant to our target groups and reflects the views of ser-
vice users and their families. During phases 2 and 3, YP
will be involved in the project as it develops, including, for
example, in the production of training materials, design
of data collection tools, data analysis and interpretation,
reporting and dissemination. Both YP and parents will
Watson et al. Pilot and Feasibility Studies  (2015) 1:8 Page 9 of 11also be supported to contribute to the Trial Steering
Committee, and parents will also contribute to the de-
velopment of the intervention through one or more
consultation groups.
Discussion
Adapting SBNT to a youth context in a manner that is
acceptable to those receiving it and that can be readily
and widely implemented in services for YP has great po-
tential for impact. If the outcome of this study suggests
that a large-scale multi-site trial is feasible, the opportun-
ity to assess the clinical and cost effectiveness of this inter-
vention could be highly valuable. In terms of benefits to
society, should Y-SBNT prove clinically and cost effective
and widely implemented, it would have a significant im-
pact on the effectiveness of young people’s drug and alco-
hol treatment and associated health and social problems,
thus reducing the costs to society. However, in addition to
acceptability to YP, successfully implementing such an
intervention is reliant on its acceptability to both those de-
livering it and those managing the services; an aspect this
study team will be exploring. The need to design and trial
a realistic intervention that can be readily delivered even
in a climate of cuts for treatment services is a key aim of
the present study.
Involving those who are the focus of the research can
have a positive impact on what is researched, how re-
search is conducted and the impact of research findings
[56]. In recent years, there has been a theoretical and
methodological shift amongst social researchers away from
traditional approaches which saw children and young
people mainly as objects of enquiry and towards a view
that they are social actors, with their own unique views
and insight into their own reality [57,58]. Although there
is less of an evidence base in relation to children and
young people’s involvement in research practice compared
to adults [59], the case for their involvement has been
explored in a number of publications [29,60-62].
An important feature of this study thus far has been
the YP’s involvement in the development stage of the
intervention which has allowed us to explore ways in
which YP with experience of using drug and alcohol ser-
vices can be involved in a study of this nature. This
study is also piloting PPI with a cohort of young people
whose voices are seldom heard in research. The project
team had originally planned to recruit a group of young
people who would be actively engaged throughout the
project on an ongoing basis through a London-based
‘young advisors’ group. However, whilst we are continuing
to pursue this option, we are also exploring more flexible
and accessible options to enable more young people to be
involved in the ways that work best for them. The valuable
insights from this work will help to shape future PPI
should a larger trial take place. Working collaborativelywith young people involved in this study, we will seek
to develop a model of PPI which addresses some of the
issues emerging from this pilot. Designing a model for
involvement with young people will enable us to reflect
together on emerging learning, ensure that PPI in a larger
trial is embedded from the outset and also contribute to
the emerging evidence base and current debates around
PPI with children and young people [63].
In addition to the development of a model of PPI, the
exploration of the feasibility aspects of the trial, the adap-
tation of the approach and the ability to recommend mov-
ing to a definitive trial or not, there are a number of other
resulting learning opportunities linked to research meas-
urement. The measurement of substance use in this young
client group is not without challenge. The complex nature
of poly-substance use and the use of legal as well as illegal
substances in complex patterns can create challenges
when attempting to obtain accurate and clinically mean-
ingful measurement and monitoring change and improve-
ment in this group. The best ways to assess these will be
explored with the use of the TLFB method which allows
a detailed exploration of all substances used over the 3-
month time period. In addition, the appropriateness of
certain family-focused measures for this client group
will also be explored. Some of the living circumstances
of young people with substance misuse problems are
away from family of origin or indeed away from family
life (e.g. living in hostel accommodation at a very early
age). How measures based on more traditional concepts
of family life are perceived by the participants and how
relevant the questions are to them is an important area
to explore and understand further.
Finally, the mixed methods used will allow for a mean-
ingful understanding of processes of delivery and imple-
mentation that to date tend to be neglected in clinical
research.
Trial status
At the time of submission, participants are actively being
recruited into this study. First participant was randomised
30/05/2014.
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